• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何选择将由卫生技术评估(HTA)进行评估的卫生技术?优先排序标准综述。

How to choose health technologies to be assessed by HTA? A review of criteria for priority setting.

作者信息

Specchia Maria Lucia, Favale Marcella, Di Nardo Francesco, Rotundo Giovanna, Favaretti Carlo, Ricciardi Walter, de Waure Chiara

机构信息

Istituto Sanità pubblica, Sezione Igiene, Università Cattolica del Sacro Cuore, Roma, Italy.

Oxford University Hospital, John Radcliffe Stroke Unit, Headington, Oxford, UK.

出版信息

Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):39-44.

PMID:26499414
Abstract

INTRODUCTION

Health Technology Assessment (HTA) plays a key role in the policy and decision-making process. Nevertheless, it is time- and resource-consuming, and therefore requires proper resource allocation. Priority setting, as a best way to organize effective and explicit resource allocation systems, may be applied even in this field.

OBJECTIVE

The aim of this study was to provide an overview of criteria used for priority setting in HTA at European level.

METHODS

A systematic review of the scientific literature was performed through PubMed alongside consultation of the websites of the European HTA Agencies belonging to the INAHTA. The search was limited to papers written in English and provided with the full text. Documents were considered eligible if providing criteria for priority setting in HTA.

RESULTS

Seven scientific articles were retrieved from PubMed and 14 European HTA Agencies released prioritization criteria were analysed. The most relevant criteria were: frequency/burden of disease, economic impact and costs, potential benefits, impact on ethical, social, cultural and/or legal aspects.

CONCLUSION

This work is meant to contribute to supranational discussion on priority setting at European level and shows that, despite the available evidence, work still needs to be done toward harmonization and sharing of the criteria to adopt.

摘要

引言

卫生技术评估(HTA)在政策和决策过程中发挥着关键作用。然而,它耗时且耗费资源,因此需要合理分配资源。作为组织有效且明确的资源分配系统的最佳方式,优先级设定甚至可应用于该领域。

目的

本研究旨在概述欧洲层面卫生技术评估中用于优先级设定的标准。

方法

通过PubMed对科学文献进行系统综述,并查阅属于国际卫生技术评估机构网络(INAHTA)的欧洲卫生技术评估机构的网站。搜索仅限于英文撰写且提供全文的论文。若文献提供了卫生技术评估中优先级设定的标准,则被视为合格。

结果

从PubMed检索到7篇科学文章,并分析了14个欧洲卫生技术评估机构发布的优先级设定标准。最相关的标准为:疾病的频率/负担、经济影响和成本、潜在益处、对伦理、社会、文化和/或法律方面的影响。

结论

本研究旨在推动欧洲层面关于优先级设定的超国家讨论,并表明尽管已有相关证据,但在采用标准的协调与共享方面仍需开展工作。

相似文献

1
How to choose health technologies to be assessed by HTA? A review of criteria for priority setting.如何选择将由卫生技术评估(HTA)进行评估的卫生技术?优先排序标准综述。
Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):39-44.
2
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review.选择观察等待或主动监测作为治疗方法的成年人的经历:一项定性系统评价。
JBI Database System Rev Implement Rep. 2016 Feb;14(2):174-255. doi: 10.11124/jbisrir-2016-2270.
6
The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.用于可视化耐药性癫痫患者手术候选者致痫灶的技术的临床有效性和成本效益:系统评价和决策分析模型。
Health Technol Assess. 2012;16(34):1-157, iii-iv. doi: 10.3310/hta16340.
7
Priority setting for health technology assessment at CADTH.加拿大药物和技术评估署(CADTH)的卫生技术评估优先排序。
Int J Technol Assess Health Care. 2010 Jul;26(3):341-7. doi: 10.1017/S0266462310000383.
8
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.用于识别下肢溃疡患者外周动脉疾病的自动化设备:证据综合和成本效益分析。
Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912.

引用本文的文献

1
Prioritisation of candidates for HTA: insights from the Indian healthcare landscape.卫生技术评估候选对象的优先排序:来自印度医疗保健领域的见解
BMJ Evid Based Med. 2025 May 10. doi: 10.1136/bmjebm-2023-112566.
2
An innovative tool to prioritize the assessment of investigational COVID-19 therapeutics: A pilot project.一种用于确定新型冠状病毒肺炎(COVID-19)研究性治疗评估优先级的创新工具:一个试点项目。
Can Commun Dis Rep. 2024 Oct 3;50(10):357-364. doi: 10.14745/ccdr.v50i10a04. eCollection 2024 Oct.
3
Topic identification, selection, and prioritization for health technology assessment in selected countries: a mixed study design.
部分国家卫生技术评估的主题识别、选择及优先级确定:一项混合研究设计
Cost Eff Resour Alloc. 2024 Feb 6;22(1):12. doi: 10.1186/s12962-024-00513-8.
4
Assessing the potential of HTA to inform resource allocation decisions in low-income settings: The case of Malawi.评估 HTA 在低收入环境下为资源配置决策提供信息的潜力:以马拉维为例。
Front Public Health. 2022 Oct 28;10:1010702. doi: 10.3389/fpubh.2022.1010702. eCollection 2022.
5
Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries.在健康技术评估中考虑了哪些标准,以及如何对其进行评估?对西方国家和亚洲国家使用的方法学指南的综述。
Appl Health Econ Health Policy. 2021 May;19(3):281-304. doi: 10.1007/s40258-020-00634-0. Epub 2021 Jan 11.
6
Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.世界卫生组织综合证据到决策框架的制定:健康决策制定决策标准系统评价概述
Cost Eff Resour Alloc. 2020 Feb 11;18:8. doi: 10.1186/s12962-020-0203-6. eCollection 2020.